ANDER
URRUTICOECHEA RIBATE
Institut d'Investigació Biomèdica Girona
Girona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomèdica Girona (6)
2013
-
Basal/HER2 breast carcinomas Integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin)
Cell Cycle, Vol. 12, Núm. 2, pp. 225-245
2012
2011
-
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Breast Cancer Research, Vol. 13, Núm. 6
-
Evidence for a link between TNFRSF11A and risk of breast cancer
Breast Cancer Research and Treatment, Vol. 129, Núm. 3, pp. 947-954
-
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
PLoS Biology, Vol. 9, Núm. 11
2010
-
Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer
Annals of the New York Academy of Sciences, Vol. 1210, Núm. 1, pp. 86-92